INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
Werte in diesem Artikel
NEW YORK, March 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Teleflex Incorporated ("Teleflex" or the "Company") (NYSE: TFX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Teleflex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On February 27, 2025, in a series of press releases, Teleflex announced its intent "to create a new, independently publicly traded company . . . consisting of Teleflex's Urology, Acute Care, and OEM businesses"; its "ent[ry] into a definitive agreement to acquire substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG for an estimated cash payment on closing of approximately €760 million"; and the resignation of Teleflex's Chief Financial Officer.
Following these announcements, Teleflex's stock price fell $38.52 per share, or 21.69%, to close $139.11 per share on February 27, 2025.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980
View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-teleflex-incorporated---tfx-302392161.html
SOURCE Pomerantz LLP
Ausgewählte Hebelprodukte auf Teleflex
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Teleflex
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Teleflex Inc.Shs
Analysen zu Teleflex Inc.Shs
Datum | Rating | Analyst | |
---|---|---|---|
02.08.2019 | Teleflex Buy | Needham & Company, LLC | |
24.04.2019 | Teleflex Buy | Needham & Company, LLC | |
22.02.2019 | Teleflex Strong Buy | Needham & Company, LLC | |
16.10.2018 | Teleflex Equal Weight | Barclays Capital | |
10.09.2018 | Teleflex Strong Buy | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
02.08.2019 | Teleflex Buy | Needham & Company, LLC | |
24.04.2019 | Teleflex Buy | Needham & Company, LLC | |
22.02.2019 | Teleflex Strong Buy | Needham & Company, LLC | |
10.09.2018 | Teleflex Strong Buy | Needham & Company, LLC | |
03.08.2018 | Teleflex Buy | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
16.10.2018 | Teleflex Equal Weight | Barclays Capital | |
16.11.2017 | Teleflex Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Teleflex Inc.Shs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen